2018

Predicting clinical benefits of combined bevacizumab and paclitaxel therapy for HER-2 negative metastatic breast cancer: a serum NMR metabolomics investigation

Congress : EUROMAR

Authors : Elodie Jobard, Jean-Yves Pierga, François-Clément Bidard, Véronique Lorgis, Gilles Romieu, Anthony Goncalves, Marc Debled, Christelle Levy, Jean-Marc Ferrero, Christelle Jouannaud, Elisabeth Luporsi, Marie-Ange Mouret-Reynier, Florence Dalenc, Jerôme Lemonnier, Bénédicte Elena-Herrmann and Olivier Trédan.

Experts group or program : French Breast Cancer Intergroup (UCBG)